Study design
BLIND
This 8-week randomized, single blind, controlled trial (RCT) (ClinicalTrials.gov ID: NCT05123261) was conducted in northern and central Taiwan after receiving approval of the study protocol granted by our hospital’s Internal Review Board (13MMHIS244). Effects of the MBEC intervention were evaluated with a pretest–posttest design at four time-points, including baseline, mid-intervention, post-intervention, and 4-week follow-up (T